COMP <GO>
AGL vs VMD // RETURN ON INVESTED CAPITAL (ROIC)
agilon health inc. (NYSE) VS. Viemed Healthcare Inc. (NASDAQ) • 15-METRIC TALLY: AGL 1
— VMD 8
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: VMD
LAST: $85.94 (-5.56%) • MKT CAP: $1.44B
roic
-35.00%
LAST: $9.95 (-0.40%) • MKT CAP: $379.0M
roic
13.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AGL VS. VMD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AGL | VMD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 57.50% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | 13.00% | -48.00 | VMD | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 6.6x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -8.25% | 3.15% | -11.40 | VMD | /fcf-yield <GO> |
| Operating Margin | -7.80% | 8.50% | -16.30 | VMD | /operating-margins <GO> |
| Net Profit Margin | -6.60% | 5.70% | -12.30 | VMD | /net-margins <GO> |
| Revenue Growth (YoY) | -2.10% | 20.50% | -22.60 | VMD | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.06 | 6.59 | -4.53 | VMD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 9/9 | -6.00 | VMD | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 44.0 | 53.1 | -9.10 | VMD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 20.7x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $1.44B | $379.0M | $1.06B | AGL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AGL REV | VMD REV | AGL GROSS % | VMD GROSS % | AGL FCF | VMD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $5.93B | $270.3M | — | 57.5% | -$119.0M | $11.9M |
| FY 2024 | $6.06B | $224.3M | — | 59.4% | -$71.0M | $1.3M |
| FY 2023 | $4.32B | $183.0M | — | — | -$156.2M | $45.2M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AGL // BETA —
VMD // BETA —